Publikationen, an denen er mitarbeitet Fernando Gandia Herrero (15)

2024

  1. Design, Synthesis and Gene Modulation Insights into Pigments Derived from Tryptophan-Betaxanthin, Which Act against Tumor Development in Caenorhabditis elegans

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Exploring in the classroom the relationship between alcohol intake and behavioral disorders through an animal model

    Biochemistry and Molecular Biology Education

  3. Novel Re(I) Complexes as Potential Selective Theranostic Agents in Cancer Cells and In Vivo in Caenorhabditis elegans Tumoral Strains

    Journal of Medicinal Chemistry, Vol. 67, Núm. 10, pp. 7891-7910

  4. Olive oil tyrosols reduce α-synuclein aggregation in vitro and in vivo after ingestion in a Caenorhabditis elegans Parkinson's model

    Food and Function

2023

  1. Characterization of betalain-loaded liposomes and its bioactive potential in vivo after ingestion

    Food Chemistry, Vol. 407

  2. Consumption of commonly used artificial food dyes increases activity and oxidative stress in the animal model Caenorhabditis elegans

    Food Research International, Vol. 169

2022

  1. Bioactive potential and spectroscopical characterization of a novel family of plant pigments betalains derived from dopamine

    Food Research International, Vol. 162

  2. Polyphenols from traditional Chinese medicine and Mediterranean diet are effective against Aβ toxicity in vitro and in vivo in Caenorhabditis elegans

    Food and Function, Vol. 13, Núm. 3, pp. 1206-1217

  3. Potent anticancer activity of a novel iridium metallodrug via oncosis

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 10

2021

  1. Biosynthesis of a novel polymeric chitosan-betaxanthin and characterization of the first sugar-derived betalains and their effects in the in vivo model Caenorhabditis elegans

    Carbohydrate Polymers, Vol. 252

  2. Flavonoids’ effects on caenorhabditis elegans’ longevity, fat accumulation, stress resistance and gene modulation involve mTOR, SKN-1 and DAF-16

    Antioxidants, Vol. 10, Núm. 3, pp. 1-17

  3. Novel organo-osmium(ii) proteosynthesis inhibitors active against human ovarian cancer cells reduce gonad tumor growth in: Caenorhabditis elegans

    Inorganic Chemistry Frontiers, Vol. 8, Núm. 1, pp. 141-155

2020

  1. Antitumoral drug potential of tryptophan-betaxanthin and related plant betalains in the caenorhabditis elegans tumoral model

    Antioxidants, Vol. 9, Núm. 8, pp. 1-17

  2. Betalain health-promoting effects after ingestion in Caenorhabditis elegans are mediated by DAF-16/FOXO and SKN-1/Nrf2 transcription factors

    Food Chemistry, Vol. 330

2019

  1. Extension of life-span using a RNAi model and in vivo antioxidant effect of Opuntia fruit extracts and pure betalains in Caenorhabditis elegans

    Food Chemistry, Vol. 274, pp. 840-847